In the field of outcome research, instruments (tools used to measure outcomes) are a potential source of health inequity. This is because they are often developed and tested in populations who regularly take part in research i.e. predominantly white, middle class and well-educated. As a result, they may not measure the outcome as well when applied to under-represented populations.

The aim of this working group is to describe the key questions for researchers to consider to promote health equity when developing or using outcome measures in rheumatology. We will discuss the key ways that population differences can be considered when developing or selecting an instrument for a study.



Screen Shot 2020-09-25 at 3.43.50 PM

Jennifer Barton:

Screen Shot 2020-09-25 at 3.44.49 PM

Peter Brooks:

Screen Shot 2020-09-17 at 4.35.38 PM

Francis Guillemin:

Screen Shot 2020-09-25 at 3.44.20 PM

Jennifer Petkovic:

Peter Tugwell

Peter Tugwell:


Aimee Wattiaux


Screen Shot 2020-09-25 at 3.59.08 PM

Willemina Campbell


Screen Shot 2020-09-25 at 3.54.47 PM

Regina Greer-Smith


Screen Shot 2020-09-23 at 9.16.35 AM

Catherine Hofstetter


Cheryl Barnabe
Christie Bartels
Jennifer Barton
Dorcas Beaton
Annelies Boonen
Peter Brooks
Rachelle Buchbinder
Willemina Campbell
Robin Christensen
Maarten de Wit
Jonathan Epstein
Niti Goel
Allyson Jones

Charles Goldsmith
Regina Greer Smith
Glen Hazelwood
Catherine Hofstetter
Jenny Humphreys
Janet Jull
Diane Lacaille
Alex Lee
Anne Lyddiatt
Lara Maxwell
Sabrina Mai Neilsen
Jordi Pardo Pardo
Adewale O Adebajo

Jennifer Petkovic
Christoph Pohl
Tamara Rader
Nancy Santesso
Bev Shea
Jasvinder Singh
Antoine Sreih
Karine Toupin-April
Peter Tugwell
Valerie Umaefulam
Aimée Wattiaux
Vivian Welch
Grayson Schultz